Gault M H, Cohen M W, Kahana L M, Leelin F T, Meakins J F, Aronovitch M
Can Med Assoc J. 1967 Jan 14;96(2):87-94.
Serial determinations of serum lactic-acid dehydrogenase (LDH), phosphohexose isomerase (PHI), alkaline phosphatase (AP), and glutamic oxaloacetic transaminase (GOT) were carried out in 30 patients with primary and four with secondary neoplasms of the lung. Enzyme values were correlated with the stage of illness, with tumour histology, with chemotherapy and with the extent and site of metastases as determined at autopsy. The activity of the enzymes LDH and PHI was most frequently elevated; their values correlated closely. AP and GOT tended to become elevated only shortly before death. Although, in general, enzyme activity increased with tumour extension and often in relation to chemotherapy, assays provided little assistance in early diagnosis or prognosis except that, in most instances, elevated values of any of the four enzymes indicated the presence of metastases.
对30例原发性肺癌患者和4例继发性肺癌患者进行了血清乳酸脱氢酶(LDH)、磷酸己糖异构酶(PHI)、碱性磷酸酶(AP)和谷草转氨酶(GOT)的系列测定。酶值与疾病分期、肿瘤组织学、化疗以及尸检确定的转移范围和部位相关。LDH和PHI的活性最常升高;它们的值密切相关。AP和GOT往往仅在死亡前不久升高。虽然一般来说,酶活性随肿瘤扩展而增加,且常常与化疗有关,但除了在大多数情况下,这四种酶中任何一种酶值升高表明存在转移外,这些测定对早期诊断或预后几乎没有帮助。